• Danish Pharmacovigilance Update, 17 January 2013

    | 26 March 2013 |

    In this issue of Danish Pharmacovigilance Update: The Pharmacovigilance Risk Assessment Committee, PRAC, finds that the risks outweigh the benefits from the use of Tredaptive®

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.